Facial Injectables Market Revenue Opportunies By Key Vendors Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc

Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial injectable are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers such as calcium hydroxyl apatite. The use of injectable products such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. These factors are anticipated to drive the market growth over the forecast years. Moreover, increasing demand for products that enhance personal beauty, rising consciousness about aesthetics, introduction of cost-effective facial injectable, and growing inclination towards minimally invasive procedures is anticipated to fuel the market growth.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1329

The global facial injectables market was valued at US$ 6,253.7 million in 2016 and is expected to exhibit a robust CAGR of 11.9% over the forecast period (2018–2026).

Increasing demand for non-surgical procedures for facial rejuvenation and correction is expected to be a factor augmenting growth of the facial injectables market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, surgical and non-surgical cosmetic procedures exhibited an overall increase of 9% from 2016-2017. ISAPS also stated that nonsurgical procedures including injectable accounted for around 8,548,597 in 2016, globally. According to the British Association of Aesthetic Plastic Surgeons, 2013, anti-ageing facelifts and brow lifts cosmetic operations exhibited a 17% rise as compared to the year 2012 globally, thus indicating rise in adoption of facial injectable.

North America is dominant in the global facial injectables market, owing to increasing awareness about advanced beauty treatments and growing emphasis about physical appearance. According to research by Galderma S.A., 2017, around 2 million women in the U.S. regularly undergo aesthetic injectable procedures, while around 17 million are considering aesthetic injectable treatment, thereby, leading to increasing demand for facial injectable. Also, according to the American Society of Aesthetic Plastic Surgery, 2016, an increase of 93% in non-surgical procedures was observed in men and women aged 35–55 years from 2011-2016. Moreover, launch of novel products in thez region by key players is a major factor accelerating the market growth. For instance, in 2016, Allergan Plc., launched an additional product in Juvederm collection of fillers, Juvederm Volbella XC, for lip augmentation and for correction of perioral rhytids, referred as lipstick lines, in adults over the age of 21. Juvéderm Volbella XC is the only filler proven to last for one year in both the lips and perioral rhytids with optimal treatment.

Supportive government and non-government initiatives to accelerate the market growth

Various organizations are conducting educational programs, scientific meetings to provide knowledge about the latest research and procedures, in turn increasing awareness among patients and plastic surgeons, thus bolstering the market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, dedicated to promote excellence in the field of aesthetic plastic surgery globally. The Society offers instructional courses, symposia, and educational programs, while the members of ISAPS have access to the most advanced techniques such as botulinum toxin and dermal fillers. Moreover, the American Academy of Facial Esthetics (AAFE) aims to provide information about non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide. AAFE is also committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1329

Key players are adopting collaborations and product launches strategies in order to address the unmet aesthetic needs thereby, providing physicians with new and better options, augmenting growth of facial injectables market. For instance, in 2017, Galderma collaborated with Colorescience to expand its skincare solutions for individuals that can be used in conjunction with conventional facial injectable aesthetic treatments.

Global Facial Injectables Market, By Product Type:
Dermal Fillers
Hyaluronic Acid Fillers
Collagen Fillers
Synthetic Fillers
Anti-wrinkle Injection
Botulinum Toxin A
Poly-L-lactic Acid (PLLA)
Global Facial Injectables Market, By Application:
Wrinkle Reduction
Facelift
Lip Enhancement
Others
Global Facial Injectables Market, By End User:
Hospitals
Dermatology Centers
Beauty Clinics
Others

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.